| HRIOX | OSMNX | HRIOX / OSMNX | |
| Total Expense Ratio | 1.25 | 1.63 | 77% |
| Annual Report Gross Expense Ratio | 2.12 | 1.63 | 130% |
| Fund Existence | 4 years | 25 years | - |
| Gain YTD | 17.350 | 2.780 | 624% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 25000 | 1000 | 2,500% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 307M | 2.55B | 12% |
| Annual Yield % from dividends | 1.17 | 1.26 | 93% |
| Returns for 1 year | 65.16 | -4.35 | -1,497% |
| Returns for 3 years | 130.55 | -15.32 | -852% |
| Returns for 5 years | N/A | -34.89 | - |
| Returns for 10 years | N/A | 4.80 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AIOCX | 11.64 | 0.16 | +1.39% |
| American Century International Opps C | |||
| FVILX | 6.30 | 0.07 | +1.12% |
| Forester Value I | |||
| GIRVX | 8.98 | 0.01 | +0.11% |
| Goldman Sachs Intl Eq Div & Prem Inv | |||
| GIEYX | 16.54 | N/A | N/A |
| GuideStone Funds International Eq Instl | |||
| JFNSX | 77.29 | -0.49 | -0.63% |
| Janus Henderson Global Life Sciences S | |||